We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-14.95%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$1.72B
AUM Growth
-$950M
Cap. Flow
-$368M
Cap. Flow %
-21.39%
Top 10 Hldgs %
48.56%
Holding
373
New
67
Increased
88
Reduced
111
Closed
78

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$59.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$32.9M
3
AMGN icon
Amgen
AMGN
+$18M
4
LLY icon
Eli Lilly
LLY
+$15.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$7.23M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$6.04M
2
ABT icon
Abbott
ABT
+$4.77M
3
RGNX icon
Regenxbio
RGNX
+$4.1M
4
CELG
Celgene Corp
CELG
+$3.94M
5
UTHR icon
United Therapeutics
UTHR
+$3.59M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Financials 0.23%
3 Consumer Staples 0.05%
4 Technology 0.03%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVXS
351
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-10,000
Closed -$412K
NVIV
352
CALL
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
0
– -$135K
CASC
353
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-39,817
Closed -$392K
CEMP
354
CALL
DELISTED
Cempra, Inc.
CEMP
– –
-3,019
Closed -$7.31M
CEMP
355
PUT
DELISTED
Cempra, Inc.
CEMP
– –
-6,323
Closed -$15.3M
SGYPW
356
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
– –
-348,743
Closed -$124K
SGYPW
357
PUT
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
– –
-3,842
Closed -$2.12M
PVCT
358
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
– –
-1,077,555
Closed -$107K
DRWI
359
DELISTED
DragonWave Inc
DRWI
– –
-378,338
Closed -$1.02M
ZGNX
360
DELISTED
Zogenix, Inc.
ZGNX
– –
-150,000
Closed -$1.65M
RXII
361
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-141,000
Closed -$49K
RXII
362
PUT
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-1,624
Closed -$57K
BDSI
363
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-1,770
Closed -$478K
CELG
364
CALL
DELISTED
Celgene Corp
CELG
– –
-3,451
Closed -$36.1M
CELG
365
DELISTED
Celgene Corp
CELG
– –
-37,728
Closed -$3.94M
CELG
366
PUT
DELISTED
Celgene Corp
CELG
– –
-2,415
Closed -$25.2M
SHPG
367
CALL
DELISTED
Shire pic
SHPG
– –
-698
Closed -$13.5M
SHPG
368
DELISTED
Shire pic
SHPG
– –
-31,172
Closed -$6.04M
SHPG
369
PUT
DELISTED
Shire pic
SHPG
– –
-698
Closed -$13.5M
11 12 13 14
15

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sabby Management held 373 positions worth $1.72B, down 36% from $2.67B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sabby Management withdrew a net $368M in Q4 2016, closing 78 positions and reducing 111 holdings. Its most notable exit was Shire pic, an estimated $6.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 9.2% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Sabby Management opened a new position in Eli Lilly worth $15.7M.

  • Sabby Management's largest Q4 2016 buy was Eli Lilly: 213,113 shares worth $15.7M.
  • Sabby Management added most to Sarepta Therapeutics in Q4 2016, an estimated $59.4M increase.
  • Sabby Management's biggest Q4 2016 reduction was Regenxbio, cutting an estimated $4.1M.
  • Sabby Management fully exited Shire pic in Q4 2016, selling an estimated $6.04M.
  • Sabby Management's ten largest holdings make up 49% of its $1.72B portfolio in Q4 2016.
  • Sabby Management opened 67 new positions and closed 78 in Q4 2016.
  • Sabby Management's portfolio value fell 36% quarter-over-quarter to $1.72B.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.